{"DataElement":{"publicId":"7101142","version":"1","preferredName":"Lung Cancer AJCC Edition 8 Pathologic Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for lung cancer based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"AJLG202P","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7100299","version":"1","preferredName":"Questionnaire Domain Lung Neoplasm Pathologic N Category","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire._One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6607890v1.0:7100297v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6607890","version":"1","preferredName":"Questionnaire Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","longName":"C49609","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Questionnaire Domain","conceptCode":"C49609","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to questionnaire.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1D6CF4-BA8C-2E63-E053-F662850A5BE1","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7100297","version":"1","preferredName":"Lung Neoplasm Pathologic N Category","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Caused by or altered by or manifesting disease or pathology.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"C12468:C3262:C25610:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A166D0D-A267-2ED5-E053-F662850AB2BD","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-19","modifiedBy":"ONEDATA","dateModified":"2019-12-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9A166D0D-A278-2ED5-E053-F662850AB2BD","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-19","modifiedBy":"HARTLEYG","dateModified":"2020-06-17","changeDescription":"Created for CDSIC aligned NCI Standard CRFs. wz","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6005948","version":"1","preferredName":"Lung Carcinoma American Joint Committee on Cancer Edition 8 N Category","preferredDefinition":"A finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v8 classification system. This classification system derives from analyses of the new retrospective and prospective databases of the International Association for the Study of Lung Cancer (IASLC). These databases contain information on patients diagnosed with lung cancer from 1999 to 2010 originating from 35 different databases in 16 countries around the world. This classification system applies to carcinomas of the lung, including non-small cell and small cell carcinomas, and bronchopulmonary carcinoid tumors. It does not apply to sarcomas or other rare tumors of the lung. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6005948v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"Lung Cancer pN3 TNM Finding v8","ValueMeaning":{"publicId":"6006154","version":"1","preferredName":"Lung Cancer pN3 TNM Finding v8","longName":"6006154","preferredDefinition":"Lung cancer with metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pN3 TNM Finding v8","conceptCode":"C136463","definition":"Lung cancer with metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BFB7509-CA5E-0285-E053-F662850AEF44","latestVersionIndicator":"Yes","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BFB7509-CA77-0285-E053-F662850AEF44","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"ONEDATA","dateModified":"2017-10-20","deletedIndicator":"No"},{"value":"N1","valueDescription":"Lung Cancer pN1 TNM Finding v8","ValueMeaning":{"publicId":"6006158","version":"1","preferredName":"Lung Cancer pN1 TNM Finding v8","longName":"6006158","preferredDefinition":"Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pN1 TNM Finding v8","conceptCode":"C136461","definition":"Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BFB7509-CAAA-0285-E053-F662850AEF44","latestVersionIndicator":"Yes","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BFB7509-CAC3-0285-E053-F662850AEF44","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"ONEDATA","dateModified":"2017-10-20","deletedIndicator":"No"},{"value":"N2","valueDescription":"Lung Cancer pN2 TNM Finding v8","ValueMeaning":{"publicId":"6006156","version":"1","preferredName":"Lung Cancer pN2 TNM Finding v8","longName":"6006156","preferredDefinition":"Lung cancer with metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pN2 TNM Finding v8","conceptCode":"C136462","definition":"Lung cancer with metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BFB7509-CA84-0285-E053-F662850AEF44","latestVersionIndicator":"Yes","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BFB7509-CA9D-0285-E053-F662850AEF44","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"ONEDATA","dateModified":"2017-10-20","deletedIndicator":"No"},{"value":"N0","valueDescription":"Lung Cancer pN0 TNM Finding v8","ValueMeaning":{"publicId":"6006160","version":"1","preferredName":"Lung Cancer pN0 TNM Finding v8","longName":"6006160","preferredDefinition":"Lung cancer without regional lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pN0 TNM Finding v8","conceptCode":"C136460","definition":"Lung cancer without regional lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BFB7509-CAD0-0285-E053-F662850AEF44","latestVersionIndicator":"Yes","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BFB7509-CAE9-0285-E053-F662850AEF44","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"ONEDATA","dateModified":"2017-10-20","deletedIndicator":"No"},{"value":"NX","valueDescription":"Lung Cancer pNX TNM Finding v8","ValueMeaning":{"publicId":"6006162","version":"1","preferredName":"Lung Cancer pNX TNM Finding v8","longName":"6006162","preferredDefinition":"Lung cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pNX TNM Finding v8","conceptCode":"C136459","definition":"Lung cancer in which the regional lymph nodes cannot be assessed.  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BFB7509-CAF6-0285-E053-F662850AEF44","latestVersionIndicator":"Yes","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BFB7509-CB0F-0285-E053-F662850AEF44","beginDate":"2017-10-20","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-20","modifiedBy":"ONEDATA","dateModified":"2017-10-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6686852","version":"1","preferredName":"Lung Cancer TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v8 classification system. This classification system derives from analyses of the new retrospective and prospective databases of the International Association for the Study of Lung Cancer (IASLC). These databases contain information on patients diagnosed with lung cancer from 1999 to 2010 originating from 35 different databases in 16 countries around the world. This classification system applies to carcinomas of the lung, including non-small cell and small cell carcinomas, and bronchopulmonary carcinoid tumors. It does not apply to sarcomas or other rare tumors of the lung. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C136430:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer TNM Finding v8","conceptCode":"C136430","definition":"A finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v8 classification system. This classification system derives from analyses of the new retrospective and prospective databases of the International Association for the Study of Lung Cancer (IASLC). These databases contain information on patients diagnosed with lung cancer from 1999 to 2010 originating from 35 different databases in 16 countries around the world. This classification system applies to carcinomas of the lung, including non-small cell and small cell carcinomas, and bronchopulmonary carcinoid tumors. It does not apply to sarcomas or other rare tumors of the lung. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CA19C6-D858-2DAA-E053-F662850A29A8","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-04-05","modifiedBy":"ONEDATA","dateModified":"2019-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BED5E5E-4942-331A-E053-F662850A02CA","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"TAYLORT","dateModified":"2019-04-08","changeDescription":"4/8/19 Released/NRG QC; tmt. 4/5/19 edits / AJCC Ed. 8 and FG style guide; tmt. 11/21/17 tt edit to Long Name, associated with CS/CSI. 10/19/17 tt created for standardization; supercedes VD 3744935.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318368","version":"1","longName":"Staging/Extent of Disease - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318385","version":"1","longName":"AJCC ED.8, Lung - CDISC Aligned","context":"NCI Standards"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7554868","version":"1","longName":"CTEP CDISC Staging AJCC Edition 8 Lung","context":"CTEP"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"RS_RSORRES_AJCC105","type":"CTEP CDISC CDE","context":"CTEP"},{"name":"RS_RSORRES_AJCC102_P","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 5989982 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"Pathologic N category","type":"Preferred Question Text","description":"Pathologic N category","url":null,"context":"NCI Standards"},{"name":"Pathologic N category","type":"Alternate Question Text","description":"Pathologic N category","url":null,"context":"CTEP"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What was the AJCC1-regional lymph nodes (N) category?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"AJCC1-regional lymph nodes (N) category","url":null,"context":"CTEP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"9A168C3E-6AE4-5EC7-E053-F662850A7557","latestVersionIndicator":"Yes","beginDate":"2019-12-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-12-19","modifiedBy":"CLOHNES","dateModified":"2023-03-07","changeDescription":"CDISC Aligned NCI Standard Template Text","administrativeNotes":"3/3/23 added 1 alt name, 2 AQTs, 1 classification for CTEP Harmonization project ticket request CADSR0002116 cjl; 02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}